NCT04168112View on ClinicalTrials.gov

Intracanalicular Dexamethasone Insert for Post-Corneal Cross-Linking Inflammation and Pain- The LINK Study

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 12, 2020

Primary Completion Date

October 24, 2022

Study Completion Date

April 5, 2023

Conditions
Keratoconus, UnstableCollagen CrosslinkingPostoperative Pain
Interventions
DRUG

Dextenza

Placement of intracanalicular dexamethasone insert for post-crosslinking inflammation and pain

DRUG

Prednisolone Acetate

post-crosslinking eye drop prednisolone acetate given in a tapering schedule over 1 month

Trial Locations (1)

11702

SightMD, Babylon

Sponsors

Collaborators (1)

Ocular Therapeutix, Inc.
All Listed Sponsors
collaborator

Ocular Therapeutix, Inc.

INDUSTRY

lead

Sight Medical Doctors PLLC

OTHER

NCT04168112 - Intracanalicular Dexamethasone Insert for Post-Corneal Cross-Linking Inflammation and Pain- The LINK Study | Biotech Hunter | Biotech Hunter